SPHK1 and myeloid leukemia: This notion was further supported by the strong anti-cancer effect of the SPHK inhibitor SKI-178 against myeloid leukemia through its ability to promote microtubule disruption [24], indicating a close link between SPHK and tubulin, though this relationship has not been well elucidated.